These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 9164956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.
    Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ, Fogler WE, Kleinerman ES, Saiki I.
    J Immunol; 1985 Dec 22; 135(6):4289-96. PubMed ID: 3934281
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective activation of antitumor activity of macrophages by the delivery of muramyl dipeptide using a novel polynucleotide-based carrier recognized by scavenger receptors.
    Srividya S, Roy RP, Basu SK, Mukhopadhyay A.
    Biochem Biophys Res Commun; 2000 Feb 24; 268(3):772-7. PubMed ID: 10679281
    [Abstract] [Full Text] [Related]

  • 10. Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response.
    Das L, Datta N, Bandyopadhyay S, Das PK.
    J Immunol; 2001 Mar 15; 166(6):4020-8. PubMed ID: 11238649
    [Abstract] [Full Text] [Related]

  • 11. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK, Naskar K, De T.
    Eur J Immunol; 2009 Aug 15; 39(8):2146-60. PubMed ID: 19593771
    [Abstract] [Full Text] [Related]

  • 12. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
    Medvedev AE, Fuks BB, Bovin NV, Zemliakov AE.
    Biull Eksp Biol Med; 1992 Dec 15; 114(12):626-8. PubMed ID: 1292694
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of human beta-casein fragment (54-59) and its synthetic analogue compound 89/215 against Leishmania donovani in hamsters.
    Sharma P, Singh N, Garg R, Haq W, Dube A.
    Peptides; 2004 Nov 15; 25(11):1873-81. PubMed ID: 15501518
    [Abstract] [Full Text] [Related]

  • 14. Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection.
    Bhattacharjee S, Bhattacharjee A, Majumder S, Majumdar SB, Majumdar S.
    J Antimicrob Chemother; 2012 Aug 15; 67(8):1905-14. PubMed ID: 22589456
    [Abstract] [Full Text] [Related]

  • 15. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R, Majumder N, Bhattacharyya Majumdar S, Bhattacharjee S, Banerjee S, Roy S, Majumdar S.
    Scand J Immunol; 2007 Dec 15; 66(6):671-83. PubMed ID: 18021365
    [Abstract] [Full Text] [Related]

  • 16. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE.
    J Immunol; 1987 Mar 15; 138(6):1919-25. PubMed ID: 3493291
    [Abstract] [Full Text] [Related]

  • 17. Lymphokine mediated microbicidal activity of peritoneal macrophages from Leishmania donovani infected and drug treated BALB/c mice.
    Sodhi S, Ganguly NK, Malla N, Mahajan RC.
    Jpn J Exp Med; 1989 Jun 15; 59(3):103-8. PubMed ID: 2554031
    [Abstract] [Full Text] [Related]

  • 18. Macrophage-directed delivery of doxorubicin conjugated to neoglycoprotein using leishmaniasis as the model disease.
    Sett R, Sarkar K, Das PK.
    J Infect Dis; 1993 Oct 15; 168(4):994-9. PubMed ID: 8376846
    [Abstract] [Full Text] [Related]

  • 19. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
    Mazumdar T, Anam K, Ali N.
    Vaccine; 2004 Mar 12; 22(9-10):1162-71. PubMed ID: 15003644
    [Abstract] [Full Text] [Related]

  • 20. Innate immune defense in visceral leishmaniasis: cytokine mediated protective role by allogeneic effector cell.
    Manna PP, Chakrabarti G, Bandyopadhyay S.
    Vaccine; 2010 Jan 08; 28(3):803-10. PubMed ID: 19879234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.